Key facts, as of
As of October 8, 2026, CVS Health Corporation (CVS) trades at $87.95, up 14.0% over the past year. Its 52-week range runs from $69.51 to $110.68; the price is 20.5% below that high. It is 22.6% below its all-time high of $113.65, reached in July 2015. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +31.1%, against +312.9% for the S&P 500 (SPY). It sits 0.1% above its 200-day average of $87.82, the usual sign of a long-term uptrend. Its 30-day volatility is 25.3% annualized, which we rate medium risk. It has a trailing P/E of 23.1 and a dividend yield of 3.02%.
Cite: Portfolio Terminal, "CVS Health Corporation (CVS) stock analysis", 2026-10-08. https://portfolio-terminal.com/analyse/cvs
Where it trades today
trading 45% of the way up its 52-week range
How the price has moved
How far it is from its record
CVS Health Corporation (CVS) is 22.6% below its all-time high of $113.65, reached in July 2015. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +31.1%, against +312.9% for the S&P 500 (SPY).
What to weigh before acting
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- CVS is valued near its sector range at 23.1x earnings versus 22.0x for peers, so the next move likely needs a real earnings or guidance catalyst.
- CVS carries a beta of 0.60, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- CVS remains in a bearish short-term trend and sits 20.5% below its high, which raises the bar for any thesis that depends on fast multiple expansion.
Portfolio Use Case
- CVS is more relevant for investors who want some income support alongside price appreciation, not just pure growth exposure.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in CVS.
- A recovery in price alone would not be enough to improve the view; the thesis needs confirmation from improving business or valuation signals.
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
Methodology
- Price, market cap, beta, yield, and liquidity fields for CVS come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as UNH, JNJ, PFE.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for CVS. Last refresh: Oct 8, 2026, 10:10 AM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as UNH, JNJ, PFE.
What CVS Health Corporation does
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management…
What analysts expect
CVS carries a strong buy consensus from 25 analysts, with an average price target of $115.76 versus $87.95 today (+31.6%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
CVS generated $412.64B in trailing revenue (7.1% year over year), with a 1.2% net margin, and $8.08B of free cash flow, against $62.35B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $402.07B | $55.36B | $10.38B | $1.77B | $1.40 | $7.81B |
| 2024 | $372.81B | $51.40B | $9.70B | $4.61B | $3.67 | $6.33B |
| 2023 | $357.78B | $54.43B | $14.60B | $8.34B | $6.49 | $10.39B |
| 2022 | $322.47B | $54.50B | $16.29B | $4.31B | $3.29 | $13.45B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
CVS is in 8 of the 30 ETFs we track. It weighs most in XLV: 1.76% of the fund, holding #16 of 62.
Famous investors who hold it
CVS is in the latest 13F of 1 of the 15 famous investors we follow. Ray Dalio (Bridgewater Associates) holds the most of it: 0.19% of the portfolio, position #86 of 992, as of Q2 2026.
How it sits in healthcare
Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.
The companies it competes with
CVS beside the healthcare names it is usually measured against.
What the chart is saying
Slipped under its 50-day average inside a longer uptrend.
weakening- Price is 6.1% below its 50-day average and 0.1% above its 200-day.
- RSI at 43 is neither stretched nor washed out.
- The nearest ceiling is $89.72 (+2.0%), the nearest floor $84.58 (-3.8%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
Is CVS a good investment in 2026?
CVS Health Corporation trades at a P/E ratio of 23.1, with medium volatility (25.3% annualized). Recent trend shows weakness.
What is the risk level of CVS?
Based on 30-day volatility of 25.3%, CVS has MEDIUM risk. Beta of 0.60 indicates lower sensitivity to market movements than average.
Does CVS pay dividends?
Yes, CVS Health Corporation has a dividend yield of 3.02%.
How far is CVS from its all-time high?
CVS Health Corporation is 22.6% below its all-time high of $113.65, reached in July 2015. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +31.1%, against +312.9% for the S&P 500 (SPY).
Which ETFs hold CVS?
8 of the 30 popular ETFs we track hold CVS Health Corporation. The largest weights: XLV (1.76%), VYM (0.48%), VTV (0.44%), VOO (0.18%) and JEPI (0.17%). Measured on each issuer's full holdings file, dated August 31 to September 24, 2026.
How much of VOO is CVS?
0.18%, as of August 31, 2026: CVS is holding #97 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $1.81 in CVS Health Corporation.
Which famous investors own CVS?
Ray Dalio (0.19% of Bridgewater Associates's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for CVS?
The average analyst price target for CVS Health Corporation (CVS) is $115.76 based on 25 analyst estimates, about 31.6% above the current price of $87.95. The published range runs from $103.00 to $145.00.
How much revenue does CVS generate?
CVS Health Corporation reported $412.64B in trailing twelve-month revenue. Revenue growth is running at 7.1% year over year. Net margin sits at 1.2%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare CVS with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.